86.97
Healthequity Inc stock is traded at $86.97, with a volume of 1.23M.
It is down -1.55% in the last 24 hours and up +5.84% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$88.34
Open:
$88.77
24h Volume:
1.23M
Relative Volume:
1.26
Market Cap:
$7.27B
Revenue:
$1.34B
Net Income/Loss:
$230.70M
P/E Ratio:
32.58
EPS:
2.6695
Net Cash Flow:
$440.96M
1W Performance:
-0.99%
1M Performance:
+5.84%
6M Performance:
-9.17%
1Y Performance:
-16.98%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
86.97 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
VEEV
Veeva Systems Inc
|
162.17 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
64.08 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.32 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
68.35 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
(HQY) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Is HealthEquity's improving profitability enough to offset key risks? - MSN
Brown Advisory Inc. Lowers Stake in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Why is HealthEquity (HQY) up 5.2% since last earnings report? - MSN
Reasons to hold HealthEquity stock in your portfolio for now - MSN
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Is HealthEquity's Improving Profitability Enough to Offset Key Risks? - Yahoo Finance
GW&K Investment Management LLC Grows Position in HealthEquity, Inc. $HQY - MarketBeat
Motley Fool Wealth Management LLC Has $7.99 Million Stock Position in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Shares Bought by Axiom Investors LLC DE - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Buys HealthEquity, Inc. (NASDAQ:HQY) Shares - MarketBeat
The Bull Case For HealthEquity (HQY) Could Change Following Raised Earnings Outlook And Completed Buyback Program - Yahoo Finance
HealthEquity | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity - Yahoo Finance
HealthEquity’s Healthcare Savings Powerhouse Moment: HSAs, AI & Mobile Drive Growth! - Smartkarma
Daily Brief Health Care: Parabilis Medicines, Integral Diagnostics, Healthequity Inc, ICON PLC, KT Medical Service, Leong Guan Holdings, Oramed Pharmaceuticals , Otsuka Holdings, Crism Therapeutics, TransCode Therapeutics and more - Smartkarma
One In Three Americans Delay Medical Care Due To Cost, - lifehealth.com
1 in 3 Americans delay care for cost; workers lose 7.3 hours weekly - Stock Titan
HealthEquity Research Highlights Healthcare Affordability Issues Impacting American Workers - Quiver Quantitative
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds - GlobeNewswire
HealthEquity Gains Momentum: HQY Stock Rises 3% on Strong Volume, Testing ResistanceDealer Positioning - newsline.com
What HealthEquity (HQY)'s Strong Q1, Higher Guidance and Buybacks Mean For Shareholders - simplywall.st
Norges Bank Buys New Shares in HealthEquity, Inc. $HQY - MarketBeat
Number of shareholders of HealthEquity, Inc. – NASDAQ:HQY - TradingView
Cost of goods sold of HealthEquity Inc – XETR:2HE - TradingView
A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $108 to $125 - Moomoo
ETFs Investing in HealthEquity Inc Stocks - TradingView
Asset turnover of HealthEquity Inc – XETR:2HE - TradingView
Net margin % of HealthEquity Inc – XETR:2HE - TradingView
HealthEquity Inc Cash Flow – XETR:2HE - TradingView
HealthEquity Inc Balance Sheet – XETR:2HE - TradingView
HealthEquity Inc Income Statement – XETR:2HE - TradingView
HQY Q1 2026 Earnings: EPS Surges Past Estimates by 10.1%Long-Term Guidance - newsline.com
HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen - MarketBeat
HealthEquity Inc stock (US42226C1071): Shares trade near recent highs after strong FY 2025 results - AD HOC NEWS
Westfield Capital Management Co. LP Raises Position in HealthEquity, Inc. $HQY - MarketBeat
HEALTHEQUITY INC (HQY) Stock Chart - ChartMill
(HQY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY) - Yahoo Finance
Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High? - Yahoo Finance
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110 - Moomoo
RBC Capital reiterates HealthEquity stock rating on growth outlook - Investing.com UK
RBC Capital reiterates HealthEquity stock rating on growth outlook By Investing.com - Investing.com South Africa
HealthEquity Inc (HQY) Shares Fall 3.5% -- What GF Score of 92 T - GuruFocus
HQY Reiterated by RBC Capital -- Price Target Maintained at $108 - GuruFocus
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
Legal & General Group Plc Lowers Stake in HealthEquity, Inc. $HQY - MarketBeat
Healthequity Insider Sold Shares Worth $298,490, According to a Recent SEC Filing - marketscreener.com
HealthEquity (NASDAQ: HQY) EVP Fiore sells 3,142 shares under 10b5-1 plan - Stock Titan
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wellborn Gayle Furgurson | Director |
May 28 '26 |
Option Exercise |
47.21 |
2,439 |
115,145 |
22,172 |
| Wellborn Gayle Furgurson | Director |
May 28 '26 |
Sale |
90.00 |
2,439 |
219,510 |
19,733 |
| Ladd Delano | EVP, General Counsel |
May 28 '26 |
Sale |
90.00 |
7,500 |
675,000 |
91,141 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):